Introducing the neXt generation

15 Jul 2007

Product news

Astech Projects has today launched the X products, a range of next generation products for automated drug delivery testing. Developed as a collection of unique solutions for complex, previously un-automated applications, the X range combines Astech’s long-standing automation expertise with the robust quality engineering, for which they are well known. Designed to efficiently automate and improve respiratory drug delivery tests such as Dose Content Uniformity of the Emitted Dose and Particle Size Determination, the Xelair™, Xelize™ and Xelox™ together increase throughput, improve data consistency and reduce health and safety risks. In addition, a simple upgrade path is in place so all X products are easily upgraded when required.

Utilising its experienced industrial design skills gathered over many years of developing innovative and bespoke automation solutions, Astech has developed the X range to cover all aspects of automated inhaler testing. The Xelair is a groundbreaking series of products for testing the Dose Content Uniformity of the Emitted Dose, the Xelize is an advanced range for Particle Size Determination in conjunction with the Andersen Cascade Impactor and the Xelox, is a next generation series of products for Particle Size Determination with the next generation impactor (NGI).

Astech Projects’ Sales & Marketing Director, Anthony Moran commented, “We have been working with pharma companies for many years developing bespoke automation solutions for a variety of manufacturing and testing processes. We felt the next step was really to build this experience and expertise into a new product range that was readily available to everyone as off-the-shelf solutions.” He continued “The X products have been developed by our dedicated drug delivery team to the same high standards of our bespoke platforms, providing reliable and robust automation for a range of respiratory drug tests.”

Links

Tags

Lab-on-a-ChipLab-on-a-chip (LOC) technology uses microfluidic chips, such as microarrays, to perform biochemical assays on a small scale. Benefits of lab-on-a-chip include the small volume of sample required as well as the speed of analysis. In selecting lab-on-a-chip devices consider the assay, cost, reliability, sensitivity and signal to noise ratio.Medicinal ChemistryMedicinal chemistry is a broad discipline encompassing the design, identification, synthesis and development of chemicals in drug discovery. It includes a number of techniques covering structural biology, synthetic chemistry and molecular biology. Technologies used in medicinal chemistry include ADME, lab-on-a-chip, high content screening and assay assembly.Biopharmaceutical AdvancesBiopharmaceutical advances follow the development of pharmaceuticals derived from biotechnology, also known as biotechnology medicines. Biopharmaceuticals may be produced from cell lines, plants, or microbial cells. Important considerations of biopharmaceutical use include application, cost, production process and purification.
Introducing the neXt generation